Quest Diagnostics (DGX) Consolidated Net Income (2009 - 2026)

Quest Diagnostics has disclosed Consolidated Net Income across 18 years of filings, most recently posting $324.0 million for Q2 2026.

• In Q2 2026, Consolidated Net Income rose 12.89% year-over-year to $324.0 million; the TTM figure through Jun 2026 stood at $1.1 billion (up 12.22% YoY), while the FY2025 annual figure was $1.0 billion, up 11.31% from the prior year.
• Consolidated Net Income came in at $324.0 million for Q2 2026 at Quest Diagnostics, up from $260.0 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $342.0 million in Q1 2022 to a low of $113.0 million in Q4 2022.
• Average Consolidated Net Income over 5 years is $241.3 million, with a median of $241.0 million recorded in 2023.
• Year-over-year, Consolidated Net Income sank 70.88% in 2022 and jumped 74.34% in 2023.
• Over 5 years, Consolidated Net Income stood at $113.0 million in 2022, then jumped by 74.34% to $197.0 million in 2023, then gained by 17.26% to $231.0 million in 2024, then rose by 7.79% to $249.0 million in 2025, then jumped by 30.12% to $324.0 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $324.0 million in Q2 2026, $260.0 million in Q1 2026, and $249.0 million in Q4 2025.